Skip to main content
NCBI home page
Emerging Infectious Diseases logoLink to Emerging Infectious Diseases
. 1998 Jan-Mar;4(1):37–47. doi: 10.3201/eid0401.980106

Diversity among multidrug-resistant enterococci.

B E Murray 1
PMCID: PMC2627656  PMID: 9452397

Abstract

Enterococci are associated with both community- and hospital-acquired infections. Even though they do not cause severe systemic inflammatory responses, such as septic shock, enterococci present a therapeutic challenge because of their resistance to a vast array of antimicrobial drugs, including cell-wall active agents, all commercially available aminoglycosides, penicillin and ampicillin, and vancomycin. The combination of the latter two occurs disproportionately in strains resistant to many other antimicrobial drugs. The propensity of enterococci to acquire resistance may relate to their ability to participate in various forms of conjugation, which can result in the spread of genes as part of conjugative transposons, pheromone-responsive plasmids, or broad host-range plasmids. Enterococcal hardiness likely adds to resistance by facilitating survival in the environment (and thus enhancing potential spread from person to person) of a multidrug-resistant clone. The combination of these attributes within the genus Enterococcus suggests that these bacteria and their resistance to antimicrobial drugs will continue to pose a challenge.

Full Text

The Full Text of this article is available as a PDF (66.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aarestrup F. M., Ahrens P., Madsen M., Pallesen L. V., Poulsen R. L., Westh H. Glycopeptide susceptibility among Danish Enterococcus faecium and Enterococcus faecalis isolates of animal and human origin and PCR identification of genes within the VanA cluster. Antimicrob Agents Chemother. 1996 Aug;40(8):1938–1940. doi: 10.1128/aac.40.8.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Arthur M., Molinas C., Bugg T. D., Wright G. D., Walsh C. T., Courvalin P. Evidence for in vivo incorporation of D-lactate into peptidoglycan precursors of vancomycin-resistant enterococci. Antimicrob Agents Chemother. 1992 Apr;36(4):867–869. doi: 10.1128/aac.36.4.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bates J., Jordens Z., Selkon J. B. Evidence for an animal origin of vancomycin-resistant enterococci. Lancet. 1993 Aug 21;342(8869):490–491. doi: 10.1016/0140-6736(93)91613-q. [DOI] [PubMed] [Google Scholar]
  4. Biavasco F., Miele A., Vignaroli C., Manso E., Lupidi R., Varaldo P. E. Genotypic characterization of a nosocomial outbreak of VanA Enterococcus faecalis. Microb Drug Resist. 1996 Summer;2(2):231–237. doi: 10.1089/mdr.1996.2.231. [DOI] [PubMed] [Google Scholar]
  5. Billot-Klein D., Gutmann L., Sablé S., Guittet E., van Heijenoort J. Modification of peptidoglycan precursors is a common feature of the low-level vancomycin-resistant VANB-type Enterococcus D366 and of the naturally glycopeptide-resistant species Lactobacillus casei, Pediococcus pentosaceus, Leuconostoc mesenteroides, and Enterococcus gallinarum. J Bacteriol. 1994 Apr;176(8):2398–2405. doi: 10.1128/jb.176.8.2398-2405.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bingen E. H., Denamur E., Lambert-Zechovsky N. Y., Elion J. Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant Enterococcus faecium strains in a pediatric hospital. J Clin Microbiol. 1991 Sep;29(9):1888–1892. doi: 10.1128/jcm.29.9.1888-1892.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Boyce J. M., Opal S. M., Chow J. W., Zervos M. J., Potter-Bynoe G., Sherman C. B., Romulo R. L., Fortna S., Medeiros A. A. Outbreak of multidrug-resistant Enterococcus faecium with transferable vanB class vancomycin resistance. J Clin Microbiol. 1994 May;32(5):1148–1153. doi: 10.1128/jcm.32.5.1148-1153.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boyle J. F., Soumakis S. A., Rendo A., Herrington J. A., Gianarkis D. G., Thurberg B. E., Painter B. G. Epidemiologic analysis and genotypic characterization of a nosocomial outbreak of vancomycin-resistant enterococci. J Clin Microbiol. 1993 May;31(5):1280–1285. doi: 10.1128/jcm.31.5.1280-1285.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Carlier C., Courvalin P. Emergence of 4',4"-aminoglycoside nucleotidyltransferase in enterococci. Antimicrob Agents Chemother. 1990 Aug;34(8):1565–1569. doi: 10.1128/aac.34.8.1565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chenoweth C. E., Robinson K. A., Schaberg D. R. Efficacy of ampicillin versus trimethoprim-sulfamethoxazole in a mouse model of lethal enterococcal peritonitis. Antimicrob Agents Chemother. 1990 Sep;34(9):1800–1802. doi: 10.1128/aac.34.9.1800. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Chow J. W., Kuritza A., Shlaes D. M., Green M., Sahm D. F., Zervos M. J. Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states. J Clin Microbiol. 1993 Jun;31(6):1609–1611. doi: 10.1128/jcm.31.6.1609-1611.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Chow J. W., Zervos M. J., Lerner S. A., Thal L. A., Donabedian S. M., Jaworski D. D., Tsai S., Shaw K. J., Clewell D. B. A novel gentamicin resistance gene in Enterococcus. Antimicrob Agents Chemother. 1997 Mar;41(3):511–514. doi: 10.1128/aac.41.3.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Clark N. C., Cooksey R. C., Hill B. C., Swenson J. M., Tenover F. C. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother. 1993 Nov;37(11):2311–2317. doi: 10.1128/aac.37.11.2311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Clewell D. B., Gawron-Burke C. Conjugative transposons and the dissemination of antibiotic resistance in streptococci. Annu Rev Microbiol. 1986;40:635–659. doi: 10.1146/annurev.mi.40.100186.003223. [DOI] [PubMed] [Google Scholar]
  15. Clewell D. B. Plasmids, drug resistance, and gene transfer in the genus Streptococcus. Microbiol Rev. 1981 Sep;45(3):409–436. doi: 10.1128/mr.45.3.409-436.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Clewell D. B., Weaver K. E. Sex pheromones and plasmid transfer in Enterococcus faecalis. Plasmid. 1989 May;21(3):175–184. doi: 10.1016/0147-619x(89)90041-3. [DOI] [PubMed] [Google Scholar]
  17. Coque T. M., Tomayko J. F., Ricke S. C., Okhyusen P. C., Murray B. E. Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother. 1996 Nov;40(11):2605–2609. doi: 10.1128/aac.40.11.2605. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Coudron P. E., Markowitz S. M., Wong E. S. Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium. Antimicrob Agents Chemother. 1992 May;36(5):1125–1126. doi: 10.1128/aac.36.5.1125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Derlot E., Courvalin P. Mechanisms and implications of glycopeptide resistance in enterococci. Am J Med. 1991 Sep 16;91(3B):82S–85S. doi: 10.1016/0002-9343(91)90348-2. [DOI] [PubMed] [Google Scholar]
  20. Dutka-Malen S., Molinas C., Arthur M., Courvalin P. Sequence of the vanC gene of Enterococcus gallinarum BM4174 encoding a D-alanine:D-alanine ligase-related protein necessary for vancomycin resistance. Gene. 1992 Mar 1;112(1):53–58. doi: 10.1016/0378-1119(92)90302-6. [DOI] [PubMed] [Google Scholar]
  21. Eliopoulos G. M., Wennersten C., Zighelboim-Daum S., Reiszner E., Goldmann D., Moellering R. C., Jr High-level resistance to gentamicin in clinical isolates of Streptococcus (Enterococcus) faecium. Antimicrob Agents Chemother. 1988 Oct;32(10):1528–1532. doi: 10.1128/aac.32.10.1528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ferretti J. J., Gilmore K. S., Courvalin P. Nucleotide sequence analysis of the gene specifying the bifunctional 6'-aminoglycoside acetyltransferase 2"-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol. 1986 Aug;167(2):631–638. doi: 10.1128/jb.167.2.631-638.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Fontana R., Ligozzi M., Pittaluga F., Satta G. Intrinsic penicillin resistance in enterococci. Microb Drug Resist. 1996 Summer;2(2):209–213. doi: 10.1089/mdr.1996.2.209. [DOI] [PubMed] [Google Scholar]
  24. Grayson M. L., Eliopoulos G. M., Wennersten C. B., Ruoff K. L., De Girolami P. C., Ferraro M. J., Moellering R. C., Jr Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus faecium: a 22-year review at one institution. Antimicrob Agents Chemother. 1991 Nov;35(11):2180–2184. doi: 10.1128/aac.35.11.2180. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Grayson M. L., Thauvin-Eliopoulos C., Eliopoulos G. M., Yao J. D., DeAngelis D. V., Walton L., Woolley J. L., Moellering R. C., Jr Failure of trimethoprim-sulfamethoxazole therapy in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 1990 Sep;34(9):1792–1794. doi: 10.1128/aac.34.9.1792. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Handwerger S., Perlman D. C., Altarac D., McAuliffe V. Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci. Clin Infect Dis. 1992 Mar;14(3):655–661. doi: 10.1093/clinids/14.3.655. [DOI] [PubMed] [Google Scholar]
  27. Handwerger S., Raucher B., Altarac D., Monka J., Marchione S., Singh K. V., Murray B. E., Wolff J., Walters B. Nosocomial outbreak due to Enterococcus faecium highly resistant to vancomycin, penicillin, and gentamicin. Clin Infect Dis. 1993 Jun;16(6):750–755. doi: 10.1093/clind/16.6.750. [DOI] [PubMed] [Google Scholar]
  28. Handwerger S., Skoble J., Discotto L. F., Pucci M. J. Heterogeneity of the vanA gene cluster in clinical isolates of enterococci from the northeastern United States. Antimicrob Agents Chemother. 1995 Feb;39(2):362–368. doi: 10.1128/aac.39.2.362. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Handwerger S., Skoble J. Identification of chromosomal mobile element conferring high-level vancomycin resistance in Enterococcus faecium. Antimicrob Agents Chemother. 1995 Nov;39(11):2446–2453. doi: 10.1128/aac.39.11.2446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Hodel-Christian S. L., Murray B. E. Characterization of the gentamicin resistance transposon Tn5281 from Enterococcus faecalis and comparison to staphylococcal transposons Tn4001 and Tn4031. Antimicrob Agents Chemother. 1991 Jun;35(6):1147–1152. doi: 10.1128/aac.35.6.1147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Hodges T. L., Zighelboim-Daum S., Eliopoulos G. M., Wennersten C., Moellering R. C., Jr Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens. Antimicrob Agents Chemother. 1992 Jan;36(1):121–125. doi: 10.1128/aac.36.1.121. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Jordens J. Z., Bates J., Griffiths D. T. Faecal carriage and nosocomial spread of vancomycin-resistant Enterococcus faecium. J Antimicrob Chemother. 1994 Oct;34(4):515–528. doi: 10.1093/jac/34.4.515. [DOI] [PubMed] [Google Scholar]
  33. Kjerulf A., Pallesen L., Westh H. Vancomycin-resistant enterococci at a large university hospital in Denmark. APMIS. 1996 Jun;104(6):475–479. doi: 10.1111/j.1699-0463.1996.tb00744.x. [DOI] [PubMed] [Google Scholar]
  34. Klare I., Heier H., Claus H., Böhme G., Marin S., Seltmann G., Hakenbeck R., Antanassova V., Witte W. Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community. Microb Drug Resist. 1995 Fall;1(3):265–272. doi: 10.1089/mdr.1995.1.265. [DOI] [PubMed] [Google Scholar]
  35. Klare I., Heier H., Claus H., Reissbrodt R., Witte W. vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol Lett. 1995 Jan 15;125(2-3):165–171. doi: 10.1111/j.1574-6968.1995.tb07353.x. [DOI] [PubMed] [Google Scholar]
  36. Klare I., Heier H., Claus H., Witte W. Environmental strains of Enterococcus faecium with inducible high-level resistance to glycopeptides. FEMS Microbiol Lett. 1993 Jan 1;106(1):23–29. doi: 10.1111/j.1574-6968.1993.tb05930.x. [DOI] [PubMed] [Google Scholar]
  37. Livornese L. L., Jr, Dias S., Samel C., Romanowski B., Taylor S., May P., Pitsakis P., Woods G., Kaye D., Levison M. E. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med. 1992 Jul 15;117(2):112–116. doi: 10.7326/0003-4819-117-2-112. [DOI] [PubMed] [Google Scholar]
  38. Miranda A. G., Singh K. V., Murray B. E. DNA fingerprinting of Enterococcus faecium by pulsed-field gel electrophoresis may be a useful epidemiologic tool. J Clin Microbiol. 1991 Dec;29(12):2752–2757. doi: 10.1128/jcm.29.12.2752-2757.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Moellering R. C., Jr Emergence of Enterococcus as a significant pathogen. Clin Infect Dis. 1992 Jun;14(6):1173–1176. doi: 10.1093/clinids/14.6.1173. [DOI] [PubMed] [Google Scholar]
  40. Moellering R. C., Jr, Wennersten C., Medrek T., Weinberg A. N. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci. Antimicrob Agents Chemother (Bethesda) 1970;10:335–340. [PubMed] [Google Scholar]
  41. Moreno F., Grota P., Crisp C., Magnon K., Melcher G. P., Jorgensen J. H., Patterson J. E. Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis. 1995 Nov;21(5):1234–1237. doi: 10.1093/clinids/21.5.1234. [DOI] [PubMed] [Google Scholar]
  42. Morris J. G., Jr, Shay D. K., Hebden J. N., McCarter R. J., Jr, Perdue B. E., Jarvis W., Johnson J. A., Dowling T. C., Polish L. B., Schwalbe R. S. Enterococci resistant to multiple antimicrobial agents, including vancomycin. Establishment of endemicity in a university medical center. Ann Intern Med. 1995 Aug 15;123(4):250–259. doi: 10.7326/0003-4819-123-4-199508150-00002. [DOI] [PubMed] [Google Scholar]
  43. Murray B. E. Beta-lactamase-producing enterococci. Antimicrob Agents Chemother. 1992 Nov;36(11):2355–2359. doi: 10.1128/aac.36.11.2355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Murray B. E., Singh K. V., Heath J. D., Sharma B. R., Weinstock G. M. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol. 1990 Sep;28(9):2059–2063. doi: 10.1128/jcm.28.9.2059-2063.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Murray B. E., Singh K. V., Markowitz S. M., Lopardo H. A., Patterson J. E., Zervos M. J., Rubeglio E., Eliopoulos G. M., Rice L. B., Goldstein F. W. Evidence for clonal spread of a single strain of beta-lactamase-producing Enterococcus (Streptococcus) faecalis to six hospitals in five states. J Infect Dis. 1991 Apr;163(4):780–785. doi: 10.1093/infdis/163.4.780. [DOI] [PubMed] [Google Scholar]
  46. Murray B. E. The life and times of the Enterococcus. Clin Microbiol Rev. 1990 Jan;3(1):46–65. doi: 10.1128/cmr.3.1.46. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Najjar A., Murray B. E. Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci. Antimicrob Agents Chemother. 1987 May;31(5):808–810. doi: 10.1128/aac.31.5.808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Navarro F., Courvalin P. Analysis of genes encoding D-alanine-D-alanine ligase-related enzymes in Enterococcus casseliflavus and Enterococcus flavescens. Antimicrob Agents Chemother. 1994 Aug;38(8):1788–1793. doi: 10.1128/aac.38.8.1788. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Patterson J. E., Singh K. V., Murray B. E. Epidemiology of an endemic strain of beta-lactamase-producing Enterococcus faecalis. J Clin Microbiol. 1991 Nov;29(11):2513–2516. doi: 10.1128/jcm.29.11.2513-2516.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Perichon B., Reynolds P., Courvalin P. VanD-type glycopeptide-resistant Enterococcus faecium BM4339. Antimicrob Agents Chemother. 1997 Sep;41(9):2016–2018. doi: 10.1128/aac.41.9.2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Perlada D. E., Smulian A. G., Cushion M. T. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey. J Clin Microbiol. 1997 Sep;35(9):2342–2347. doi: 10.1128/jcm.35.9.2342-2347.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Phillips I., King A., Gransden W. R., Eykyn S. J. The antibiotic sensitivity of bacteria isolated from the blood of patients in St Thomas' Hospital, 1969-1988. J Antimicrob Chemother. 1990 Apr;25 (Suppl 100):59–80. doi: 10.1093/jac/25.suppl_c.59. [DOI] [PubMed] [Google Scholar]
  53. Plessis P., Lamy T., Donnio P. Y., Autuly F., Grulois I., Le Prisé P. Y., Avril J. L. Epidemiologic analysis of glycopeptide-resistant Enterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur J Clin Microbiol Infect Dis. 1995 Nov;14(11):959–963. doi: 10.1007/BF01691377. [DOI] [PubMed] [Google Scholar]
  54. Power E. G., Abdulla Y. H., Talsania H. G., Spice W., Aathithan S., French G. L. vanA genes in vancomycin-resistant clinical isolates of Oerskovia turbata and Arcanobacterium (Corynebacterium) haemolyticum. J Antimicrob Chemother. 1995 Oct;36(4):595–606. doi: 10.1093/jac/36.4.595. [DOI] [PubMed] [Google Scholar]
  55. Rhinehart E., Smith N. E., Wennersten C., Gorss E., Freeman J., Eliopoulos G. M., Moellering R. C., Jr, Goldmann D. A. Rapid dissemination of beta-lactamase-producing, aminoglycoside-resistant Enterococcus faecalis among patients and staff on an infant-toddler surgical ward. N Engl J Med. 1990 Dec 27;323(26):1814–1818. doi: 10.1056/NEJM199012273232606. [DOI] [PubMed] [Google Scholar]
  56. Rice L. B., Carias L. L., Marshall S. H., Bonafede M. E. Sequences found on staphylococcal beta-lactamase plasmids integrated into the chromosome of Enterococcus faecalis CH116. Plasmid. 1996 Mar;35(2):81–90. doi: 10.1006/plas.1996.0010. [DOI] [PubMed] [Google Scholar]
  57. Roberts M. C. Characterization of the Tet M determinants in urogenital and respiratory bacteria. Antimicrob Agents Chemother. 1990 Mar;34(3):476–478. doi: 10.1128/aac.34.3.476. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Roberts M. C., Hillier S. L. Genetic basis of tetracycline resistance in urogenital bacteria. Antimicrob Agents Chemother. 1990 Feb;34(2):261–264. doi: 10.1128/aac.34.2.261. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Sader H. S., Pfaller M. A., Tenover F. C., Hollis R. J., Jones R. N. Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers. J Clin Microbiol. 1994 Nov;32(11):2840–2842. doi: 10.1128/jcm.32.11.2840-2842.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  61. Schouten M. A., Voss A., Hoogkamp-Korstanje J. A. VRE and meat. Lancet. 1997 Apr 26;349(9060):1258–1258. doi: 10.1016/s0140-6736(05)62461-0. [DOI] [PubMed] [Google Scholar]
  62. Seetulsingh P. S., Tomayko J. F., Coudron P. E., Markowitz S. M., Skinner C., Singh K. V., Murray B. E. Chromosomal DNA restriction endonuclease digestion patterns of beta-lactamase-producing Enterococcus faecalis isolates collected from a single hospital over a 7-year period. J Clin Microbiol. 1996 Aug;34(8):1892–1896. doi: 10.1128/jcm.34.8.1892-1896.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Thal L. A., Chow J. W., Clewell D. B., Zervos M. J. Tn924, a chromosome-borne transposon encoding high-level gentamicin resistance in Enterococcus faecalis. Antimicrob Agents Chemother. 1994 May;38(5):1152–1156. doi: 10.1128/aac.38.5.1152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Tomayko J. F., Murray B. E. Analysis of Enterococcus faecalis isolates from intercontinental sources by multilocus enzyme electrophoresis and pulsed-field gel electrophoresis. J Clin Microbiol. 1995 Nov;33(11):2903–2907. doi: 10.1128/jcm.33.11.2903-2907.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Van der Auwera P., Pensart N., Korten V., Murray B. E., Leclercq R. Influence of oral glycopeptides on the fecal flora of human volunteers: selection of highly glycopeptide-resistant enterococci. J Infect Dis. 1996 May;173(5):1129–1136. doi: 10.1093/infdis/173.5.1129. [DOI] [PubMed] [Google Scholar]
  66. Watanakunakorn C. The prevalence of high-level aminoglycoside resistance among enterococci isolated from blood cultures during 1980-1988. J Antimicrob Chemother. 1989 Jul;24(1):63–68. doi: 10.1093/jac/24.1.63. [DOI] [PubMed] [Google Scholar]
  67. Wells V. D., Wong E. S., Murray B. E., Coudron P. E., Williams D. S., Markowitz S. M. Infections due to beta-lactamase-producing, high-level gentamicin-resistant Enterococcus faecalis. Ann Intern Med. 1992 Feb 15;116(4):285–292. doi: 10.7326/0003-4819-116-4-285. [DOI] [PubMed] [Google Scholar]
  68. Zervos M. J., Dembinski S., Mikesell T., Schaberg D. R. High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. J Infect Dis. 1986 Jun;153(6):1075–1083. doi: 10.1093/infdis/153.6.1075. [DOI] [PubMed] [Google Scholar]
  69. Zervos M. J., Mikesell T. S., Schaberg D. R. Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus faecalis. Antimicrob Agents Chemother. 1986 Jul;30(1):78–81. doi: 10.1128/aac.30.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Zervos M. J., Schaberg D. R. Reversal of the in vitro susceptibility of enterococci to trimethoprim-sulfamethoxazole by folinic acid. Antimicrob Agents Chemother. 1985 Sep;28(3):446–448. doi: 10.1128/aac.28.3.446. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. van den Bogaard A. E., Jensen L. B., Stobberingh E. E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med. 1997 Nov 20;337(21):1558–1559. doi: 10.1056/NEJM199711203372117. [DOI] [PubMed] [Google Scholar]

Articles from Emerging Infectious Diseases are provided here courtesy of Centers for Disease Control and Prevention

RESOURCES